This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human JAM-C Fc Chimera Protein, CF
catalog :
1189-J3
quantity :
50 ug
price :
339 USD
citations: 3
Reference
Wolf D, Anto Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun. 2018;9:525 pubmed publisher
Arcangeli M, Bardin F, Frontera V, Bidaut G, Obrados E, Adams R, et al. Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells. Stem Cells. 2014;32:1043-54 pubmed publisher
Zen K, Babbin B, Liu Y, Whelan J, Nusrat A, Parkos C. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell. 2004;15:3926-37 pubmed
product information
brand :
R&D Systems
master code :
1189-J3
SKU :
1189-J3-050
product name :
Recombinant Human JAM-C Fc Chimera Protein, CF
description :
The Recombinant Human JAM-C Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human JAM-C Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
JAM-C
category :
Proteins and Enzymes
unit size :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in Tris-Citrate and NaCl.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
60-65 kDa, reducing conditions
theoretical molecular weight :
50 kDa (monomer)
gene symbol :
JAM3
details of functionality :
Measured by its ability to inhibit the adhesion of J45.01 human acute lymphoblastic leukemia T lymphocytes on immobilized JAM-2 (VE-JAM)/Fc Chimera. When 0.2 µg/mL (100 µL/well) of rhJAM-B/Fc Chimera is immobilized on goat anti-human IgG Fc Chimera antibody coated wells, the ED50 for this effect is 0.1-0.5 µg/mL in the presence of 1 x 105 cells/well.
endotoxin note :
<0.10 EU per 1 µg of the protein by the LAL method.
catalog number base :
1189-J3
accessionNumbers :
Q9BX67
applications :
Bioactivity
source :
Mouse myeloma cell line, NS0-derived human JAM-C protein Human JAM-C Val32 - Asn241 (Ala149Pro) Accession # Q9BX67 IEGRMD Human IgG1 (Pro100 - Lys330) N-terminus C-terminus
2020 USD :
339
2021 USD :
339 USD
alt names :
CD323, JAM-2, JAM3, JAMC, JAM-CFLJ14529, junctional adhesion molecule 3JAM-3, junctional adhesion molecule C
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.